Mohit Final Project Pharma

  • Upload
    lokesh

  • View
    222

  • Download
    1

Embed Size (px)

Citation preview

  • 8/20/2019 Mohit Final Project Pharma

    1/35

    PROJECT REPORT

    On

    Job Satisfaction of Employees in Pharmaceutical Company

    Submitted By:Mohit Gautam

     In partial fulfillment for the award of the degree

    of 

    Bachelors in Commerce (Honors Programme)

    Under the Supervision of: Submitted by:

     Dr. RAKESH KUMAR SHUKLA

    Assistant Professor 

     MOHIT GAUTAM 

    Roll No !"M#B$"%

    Ph& '! %*+!$$",$

    --&&

    #hoolini .ni/ersit0 of Biotechnolog0 1 Management #ciences2 Ba3hol2 #olan2 H&P !+4"!"&

    A55ro/e6 70 .ni/ersit0 Grants Commission2 A8CTE2 etc&

    i

  • 8/20/2019 Mohit Final Project Pharma

    2/35

    ACKNO!E"#E$EN%

    The 5ro3ect on &Job Satisfaction of Employees in Pharmaceutical Company' 9oul6 not ha/e 7een

    successful 9ithout the follo9ing 5eo5le an6 their 5riceless su55ort an6 coo5eration& Hence 8 e:ten6 m0

    gratitu6e to all of them&

    As a stu6ent of Shoolini University of Biotechnology M!n!ge"ent Sciences 9oul6 first of all li;e to

    e:5ress m0 gratitu6e to "r( Kesari Sin)h for granting me 5ermission to un6erta;e the 5ro3ect re5ort in their 

    esteeme6 organi

  • 8/20/2019 Mohit Final Project Pharma

    3/35

    P*E-ACE

    #tu6ents of B&Com (Honors) at Shoolini University are re@uire6 to un6ergo Pro3ect ?or; as an integral 5art of 

    curriculum&

    To accom5lish this 5ro3ect as &Job Satisfaction of Employees in Pharmaceutical Company ' there is nee6 to

     7ecome familiar 9ith the 5ro3ect&

    8t can 7e 5ossi7le onl0 through theoretical in5uts as 9ell as 5ractical e:5osure in 9hich m0 5ractical ;no9le6ge

    is hel5ful 9hich 8 ac@uire6 at the college&

     I have also done this study from secon#!ry so$rces.

    iii

  • 8/20/2019 Mohit Final Project Pharma

    4/35

    CE*%.-.CA%E

    This is to certif0 that the Pro3ect 9or; entitle6 &Job Satisfaction of Employees in Pharmaceutical

    Company ' su7mitte6 in 5artial fulfillment of the re@uirement for the a9ar6 of 6egree of Bachelors in

    Commerce to #hoolini .ni/ersit0 of Biotechnolog0 an6 Management #ciences2 Ba3hol2 #olan (H&P&) is a

     7onafi6e Pro3ect 9or; carrie6 out 70 Ni;un3 alra (!"M#B$")&  No 5art of this 9or; has 7een

    su7mitte6 for an0 other 6egree or 6i5loma&

     Name of #tu6ent $ohit #autam  Name of the Gui6e "r( *(K( Shu/la

    #ignature #ignature

    Place Solan

    =ate 

    iv

  • 8/20/2019 Mohit Final Project Pharma

    5/35

    %A0!E O- CON%EN%S

    %HA&TERS TITLE   &AGE

     'O.

    %h!(ter ) O*#AN.SA%.ONA! P*O-.!E

    %h!(ter * .N%*O"UC%.ON

    %h!(ter + O0JEC%.1ES

    %h!(ter , *ESEA*C+ $E%O"O!O#2

    %h!(ter -"A%A ANA!2S.S 3

    .N%E*P*E%A%.ON

    %h!(ter   -.N".N#S 3 !.$.%A%.ONS

    %h!(ter / CONC!US.ON 3

    *ECO$$EN"A%.ONS

    v

  • 8/20/2019 Mohit Final Project Pharma

    6/35

    SU$$A*2

    The Pharmaceutical sector 5la0s a /ital role in un6er5inning the economic 6e/elo5ment of a countr0& This stu60

    attem5ts to e/aluate 3o7 satisfaction of em5lo0ees in 6ifferent 5harmaceutical com5anies& 8t focuses on the

    relati/e im5ortance of 5erformance a55raisal 1 3o7 satisfaction factors an6 their im5acts on the o/erall 3o7

    satisfaction of em5lo0ees& Both 5rimar0 an6 secon6ar0 sources of information ha/e 7een consi6ere6 as a 6ata

    collection 5rocess& Primar0 6ata 9as collecte6 through chec;list an6 5ersonnel inter/ie9& At 5resent2 in

    Bangla6esh2 there are "$, national 5harmaceutical com5anies an6 onl0 + multinational or foreign com5anies

    o5erating&

    8n our sur/e0 9e foun6 e/el on 9or; con6itions2 e/el on Pa0 an6 Promotion2 e/el on Dairness2 e/el on

    Jo7 #ecurit02 e/el on Relationshi5 9ith co9or;ers2 e/el on Relationshi5 9ith imme6iate su5er/isor> 9e also

    foun6 the 5roce6ure of 5erformance a55raisal 1 em5lo0ee 3o7 satisfaction in multinational 5harmaceuticals

    Finclu6e GAO2 1 Roche 1 local 5harmaceuticals Com5an0 Finclu6es BE8MCO 1 #I.ARE&

    8n the o/erall 3o7 satisfaction summar0 9e focuse6 on the satisfaction 9ith inter5ersonal relations2 satisfaction

    9ith com5ensation 5ac;age (salar02 fringe 7enefits)2 satisfaction 9ith 5rofessional effecti/eness2 o/erall 3o7

    satisfaction&

    The results suggest that the factors ha6 satisfactoril0 e:5laine6 3o7 satisfaction an6 that the 5olic0 ma;ers an6

    managers shoul6 focus on the factors that affect em5lo0ee 3o7 satisfaction2 if the0 9ant to enhance their 

     7usinesses& Base6 on the results for the stan6ar6i

  • 8/20/2019 Mohit Final Project Pharma

    7/35

    %h!(ter )

    O*#AN.SA%.ONA! P*O-.!E

    7

  • 8/20/2019 Mohit Final Project Pharma

    8/35

    O*#AN.4A%.ONA! P*O-.!E

    The 5harmaceutical in6ustr0 s5en6s 7illions of 6ollars annuall0 on gifts to 5h0sicians often these gifts consist of

    items that are 6esigne6 to enhance 5atient care (e&g&2 anatomical oo6les) or learning (e&g&2 te:t7oo;s)2 7ut gifts

    ma0 also 7e of a more 5ersonal nature (e&g&2 /ent tic;ets)& #erious ethical concerns ha/e 7een raise6 that gifts

    from the 5harmaceutical in6ustr0 to in6i/i6ual health care 5rofessionals ris; com5romising health care

     5ro/i6ers 5rofessional o73ecti/it0 an6 integrit02 an6Kor un6ermining their fun6amental ethical commitment to

     5utting the interests of 5atients first& This re5ort 6iscusses the s5ecial nature of gift relationshi5s2 e:amines 9h0

    gifts to health care 5rofessionals from the 5harmaceutical in6ustr0 ma0 7e ethicall0 5ro7lematic2 an6 re/ie9s

     5rofessional ethical gui6elines an6 legal stan6ar6s regar6ing acce5tance of gifts&

    Health care 5rofessionals 9ho 5rescri7e 5harmaceutical 5ro6ucts 7ase their 5rescri5tion 6ecisions on man0

    factors inclu6ing effecti/eness2 safet02 an6 cost& 8n an effort to influence 5ractitioners 5rescri7ing 5ractices2 the

     5harmaceutical in6ustr0 em5lo0s 6i/erse mar;eting an6 5romotional strategies2 among them offers of free 6rug

    sam5les2 e6ucational materials2 meals2 an6 other forms of gifts& These efforts are 7oth intensi/e an6 e:5ensi/e&

    8n "$$! the 6rug in6ustr0 s5ent more than L!* 7illion on /isits to 5h0sicians offices& 8n the last fi/e 0ears the

    num7er of 5harmaceutical com5an0 sales re5resentati/es in the .& has increase6 from ,"2$$$ to %%2$$$&!

    #ome %$ of 5h0sicians re5ort ha/ing 7een offere6 cash or gifts from 5harmaceutical in6ustr0 re5resentati/es&"

    Man0 5h0sicians meet 9ith 5harmaceutical in6ustr0 re5resentati/es four or more times 5er month&4 #erious

    ethical concerns ha/e 7een raise6 a7out these contacts 7et9een the 5harmaceutical in6ustr0 an6 in6i/i6ual

    health care 5rofessionals2 es5eciall0 9hen gifts are in/ol/e6&,

    The 5ractice of acce5ting gifts from 5harmaceutical in6ustr0 re5resentati/es ris;s com5romising health care

     5ro/i6ers 5rofessional o73ecti/it0 an6 integrit02 an6 un6ermining their fun6amental ethical commitment to

     5utting the interests of 5atients first& Gift incenti/es to 5artici5ate in continuing 5rofessional e6ucation 5rograms

    are the 9rong incenti/es for health care 5rofessionals an6 trainees2 9ho shoul6 7e in6e5en6entl0 moti/ate6 to

     5artici5ate in lifelong learning&+ An6 there are economic conse@uences 9hen the costs of gifts are 5asse6 alongto 5atients2 health care institutions2 an6 thir65art0 5a0ers in the form of higher 5rices for 6rugs&

    8

  • 8/20/2019 Mohit Final Project Pharma

    9/35

    Chapter 5

    .N%*O"UC%.ON

    .N%*O"UC%.ON

    9

  • 8/20/2019 Mohit Final Project Pharma

    10/35

    8n to6a0s intensel0 com5etiti/e an6 glo7al mar;et5lace2 com5etiti/e a6/antage lies not 3ust in 6ifferentiating a

     5ro6uct or ser/ice or in 7ecoming the lo9 cost lea6er 7ut in also 7eing a7le to ta5 the com5an0s s5ecial s;ills

    or core com5etencies& Es5eciall0 for 5harmaceutical in6ustr0 s;ille6 an6 efficient em5lo0ees are must as it

    re@uires s5eciali

  • 8/20/2019 Mohit Final Project Pharma

    11/35

    em5lo0ee an6 the organi

  • 8/20/2019 Mohit Final Project Pharma

    12/35

    Chapter 6

    O0JEC%.1ES

    Ob7ectives:

    The o73ecti/es of this stu60 are

    12

  • 8/20/2019 Mohit Final Project Pharma

    13/35

    To stu60 the Jo7 #atisfaction of Em5lo0ees in Pharmaceutical Com5an0&

    To i6entif0 the factors 9hich influence the 3o7 satisfaction of em5lo0ees

    To i6entif0 the factor 9hich im5ro/es the satisfaction le/el of em5lo0ees

    13

  • 8/20/2019 Mohit Final Project Pharma

    14/35

    Chapter 8

    *ESEA*C+ $E%+O"O!O#2

    .N%*O"UC%.ON

    14

  • 8/20/2019 Mohit Final Project Pharma

    15/35

    This cha5ter focuses on the rese!rch "etho#ology 1 the techni0$es use6 for the collection, classification &

    tabulation of data& 8t 5uts light on the research 5ro7lem2 the o12ective of the st$#y 1 its li"it!tions&

    *ESEA*C+ $E%+O"O!O#2

    Research metho6olog0 is a 9a0 to systematically solve the problem& 8t is a plan for conducting research& 8n this

    9e describe various steps that are ta;en 70 the researcher &

    Research is a common 5lace for knowledge& Research is an art of scientific an6 systematic investigation& Thus

    research com5rises defining  an6 redefining problems2 formulating hypothesis or suggested solutions> collecting,

    organizing and evaluating data, making deductions and reaching conclusions&

    Research metho6olog0 is the way for collection and analysis of data in a manner  that aims to combine

    relevance to the research purpose&

    Research Metho6olog0 is the structure 9ithin 9hich research is conducted & 8t constitutes the blueprint  for the

    collection and analysis of the data&

    Research metho6olog0 is a framework  for the study an6 is use6 as a guide in collecting  an6 analyzing  the 6ata&8t is a strategy  specifying  9hich approach 9ill 7e use6 for gathering  the data& 8t also inclu6es time an6 cost 

    budget  since most stu6ies are 6one un6er these two constraints&

    %2PE O- *ESEA*C+ USE"

    15

  • 8/20/2019 Mohit Final Project Pharma

    16/35

    "escriptive *esearch

    8n the stu60 descriptive research 6esign has 7een use6& As 6escri5ti/e research 6esign is the description of state

    of affairs2 as it exists at present & 8n this t05e of research the researcher has no control o/er the /aria7les> he c!n

    only re(ort 3h!t h!s h!((ene# or 3h!t is h!((ening.

    =escri5ti/e research 6esigns are those 6esign 9hich are concerne6 9ith 6escri7ing the characteristics of 

     5articular in6i/i6ual or of the grou5& 8n 6escri5ti/e stu60 the researcher must 7e a7le to 6efine clearl0 9hat he

    9ants to measure an6 must fin6 a6e@uate metho6 for measuring it&

    $E%+O" O- "A%A CO!!EC%.ON

    After the research problem has been identified  an6 selected  the ne:t ste5 is to gather  the reuired data& The

    metho6s of 6ata collection use6 for the research are of " t05es2 5rimar0 6ata collection an6 secon6ar0 6ata

    collection&

     

    Primary "ata

    16

    PR8MAR

    =ATA

    #ECON=R

    =ATA

    TPE# OD =ATA

  • 8/20/2019 Mohit Final Project Pharma

    17/35

    The 5rimar0 6ata are those2 9hich are collecte6 fresh an6 thus ha55ene6 to 7e original  in character & ?e can

    o7tain primary data either through observation or through direct communication 9ith respondent  in one form or

    another or through 5ersonal inter/ie9&

    Secondary "ata

    The secon6ar0 6ata on the other han62 are those 9hich ha/e already been collecte6 70 someone else an6 9hich

    ha/e already 7een passed  through the statistical processes& ?hen the researcher utili

  • 8/20/2019 Mohit Final Project Pharma

    18/35

    Chapter 9

    "A%A .N%E*P*E%A%.ON 3 ANA!2S.S

    18

  • 8/20/2019 Mohit Final Project Pharma

    19/35

    19

  • 8/20/2019 Mohit Final Project Pharma

    20/35

    Chapter

    20

  • 8/20/2019 Mohit Final Project Pharma

    21/35

    -.N".N#S

    -.N".N#S

    This section 9ill tr0 to highlight an6 6iscuss the results an6 the fin6ings 7ase6 on the anal0sis 6one on the 6ata

    collecte6 from res5on6ents& This research focuses on the factors affecting em5lo0ee 3o7 satisfaction in selecte6

     5harmaceuticals com5an0& The 6iscussion then 9ill tr0 to accom5lish all the o73ecti/es of the stu60& 8n this

    instance2 for sim5licit0 of anal0sis an6 fin6ings2 this 5art focuses on the le/els of em5lo0ee 3o7 satisfaction 1

     5erformance a55raisal 5roce6ures in Pharmaceuticals Com5an0 an6 6iscussion&

     EM&LO4EES 5OB SATIS6A%TIO' I' &HARMA%EUTI%ALS %OM&A'4 

    This 5art 6iscusses the res5on6ents o/erall 5erce5tion of em5lo0ee 3o7 satisfaction in Pharmaceuticals

    Com5an0 an6 su76imensions such as 5a0 an6 5romotion2 3o7 securit02 9or; con6itions2 fairness an6

    relationshi5 9ith co9or;ers an6 management& The fin6ings are 5resente6 in fre@uencies an6 5ercentages&

    21

  • 8/20/2019 Mohit Final Project Pharma

    22/35

    Overall level of employee satisfaction in Pharmaceutical Companies

    22

  • 8/20/2019 Mohit Final Project Pharma

    23/35

    8n terms of 9or;ing con6itions2 5a0 an6 5romotion2 3o7 securit0 an6 relationshi5 9ith co9or;ers the stu60

    foun6 that the le/el of em5lo0ee 3o7 satisfaction is neither ha550 nor unha550 an6 in terms of relationshi5

    9ith imme6iate su5er/isor the le/el of em5lo0ee 3o7 satisfaction is some9hat unha550& O/erall le/el of 

    em5lo0ee satisfaction in 5harmaceutical com5anies2 the stu60 foun6 that the a/erage mean is *!2 so the

    o/erall le/el of em5lo0ee 3o7 satisfaction is neither ha550 nor unha550&

    !evel on ;or/ conditions

    8n terms of le/el on 9or; con6itions in 5harmaceuticals com5anies2 the stu60 foun6 that ,, res5on6ents

     5ercei/e6 atmos5here to 7e Neutral& A7out " res5on6ents 5ercei/e6 the 9or; con6itions to 7e ha5502

    9hile ! res5on6ents 5ercei/e6 9or; con6itions as unha550 &A fe92 + res5on6ents rate6 the 9or; con6itions

    as /er0 unha550 an6 /er0 ha550 & At last2 the mean score is 4&$!2 so the 9or; con6itions are neither 

    ha550 nor unha550& oo;ing at the mean score of 4&!$2 9e can see that 9or; con6itions influence 3o7

    satisfaction in 5harmaceuticals com5anies&

    !evel on Pay and Promotion

    8n terms of le/el on 5a0 7ac; in 5harmaceuticals com5anies2 the stu60 foun6 that , res5on6ents 5ercei/e6 5a0

    an6 5romotion to 7e neither ha550 or unha5502 "! of the res5on6ents 5ercei/e6 the 5a0 an6 5romotion to 7e

    some9hat ha550 an6 "! res5on6ents 5ercei/e6 5a0 an6 5romotion to 7e some9hat unha550& Onl0 a fe9 ,

    an6 of the res5on6ents rate6 the 5a0 an6 5romotion as /er0 unha550 an6 /er0 ha550& At last2 the mean

    score is 4&$"2 so the 5a0 an6 5romotion is some9hat unha550& Accor6ing to a mean score of 4&$"2 9e can see

    that 5a0 an6 5romotion influences 3o7 satisfaction in 5harmaceuticals com5anies&

    !evel on -airness

    8n terms of le/el a7out fairness in 5harmaceuticals com5anies2 the stu60 foun6 that ! res5on6ents 5ercei/e6fairness to 7e neither ha550 nor unha5502 ", res5on6ents 5ercei/e6 the fairness to 7e some9hat ha5502

    9hile !* res5on6ents 5ercei/e6 fairness as some9hat unha550& A fe9 * res5on6ents rate6 the fairness as

    /er0 unha550 an6 4 res5on6ents are /er0 ha550& Dinall02 the mean score is 4&$"2 so the fairness is neither 

    ha550 nor unha550& Accor6ing to the mean score of 4&$"2 9e can see that fairness influences 3o7 satisfaction in

     5harmaceuticals com5anies&

    23

  • 8/20/2019 Mohit Final Project Pharma

    24/35

    !evel on Job Security

    8n terms of le/el on 3o7 securit0 in 5harmaceuticals com5anies2 the stu60 foun6 that $ res5on6ents 5ercei/e6

     3o7 securit0 in 5harmaceuticals com5anies to 7e neither ha550 nor unha5502 ", res5on6ents 5ercei/e6 3o7

    securit0 in 5harmaceuticals com5anies to 7e some9hat ha5502 9hile !+ res5on6ents 5ercei/e6 3o7 securit0 in

     5harmaceuticals com5anies as some9hat unha550& res5on6ents rate6 3o7 securit0 as /er0 unha550 an6 ,

    res5on6ents 9ere /er0 ha550& Dinall02 the mean score is 4&$%2 so 3o7 securit0 in 5harmaceuticals com5anies is

    neither ha550 nor unha550& Accor6ing to the mean score of 4&$2 9e can see that 3o7 securit0 influences 3o7

    satisfaction in 5harmaceuticals com5anies&

    !evel on *elationship ;ith co

  • 8/20/2019 Mohit Final Project Pharma

    25/35

    E$P!O2EE SA%.S-AC%.ON =AN O1E*1.E> !OCA! CO$PAN.ES

     &erfor"!nce A((r!is!l 

    At BP a55raisals are 6one 70 the #elfa55raisal s0stem& Goals are set 70

     5artici5ati/eQmanagement a55roach an6 5erformance is e/aluate6 @uantitati/el0 against those

     5re/iousl0 set o73ecti/es& Managers a55raise the 5erformance of their su7or6inates through 5oints Gra5hic

    Rating #cale& The total a55raisal 5rocess is com5letel0 trans5arent to e/er0one 9ithin the organi

  • 8/20/2019 Mohit Final Project Pharma

    26/35

    A sur/e0 aime6 at 6etermining 5re/ailing 9age rates& A goo6 salar0 sur/e0 5ro/i6es s5ecific 9age rates for 

    s5ecific 3o7s& Dormal 9ritten @uestionnaire sur/e0s are the most com5rehensi/e2 7ut tele5hone sur/e0s an6

    ne9s5a5er a6s are also sources of information&

    Job Evaluation

    A s0stematic com5arison 6one in or6er to 6etermine the 9orth of one 3o7 relati/e to another& Jo7 E/aluation

    metho6 inclu6es

    ?( *an/in)

    8n/ol/es ran;ing each 3o7 relati/e to all other 3o7s2 usuall0 7ase6 on o/erall 6ifficult0& There are

    se/eral ste5s in this metho6

    • O7tain 3o7 information for each 3o7

    • Ran; 3o7s 70 6e5artment or in clusters

    #elect 3ust one com5ensa7le factor• Ran; 3o7s

    • Com7ine ratings

    5( Job Classification:

    Categori

  • 8/20/2019 Mohit Final Project Pharma

    27/35

     BE'E6ITS A'D RE7ARDS &A%KAGE 

    8n6irect financial an6 non financial 5a0ments em5lo0ees recei/e for continuing their em5lo0ment 9ith the

    com5an0&

    %here are several types of benefits:

    #u55lemental Pa0 Benefits• 8nsurance Benefits

    • acations an6 Holi6a0s

    • #ic; ea/e

    • Parental ea/e an6 Damil0 ea/e

    • Me6ical ea/e

    • Retirement Benefits

     He!lth S!fety

    Pre employment medical chec/

  • 8/20/2019 Mohit Final Project Pharma

    28/35

    Management staffs en3o0 health insurance for self2 s5ouse an6 t9o chil6ren u5 to "! 0ears for hos5itali

  • 8/20/2019 Mohit Final Project Pharma

    29/35

    Chapter

    CONC!US.ON

    29

  • 8/20/2019 Mohit Final Project Pharma

    30/35

    CONC!US.ONS

    Em5lo0ee 3o7 satisfaction can im5ro/e ser/ice @ualit0 an6 increase em5lo0ee satisfaction& 8n this circumstance2

     5olic0 ma;ers an6 managers ha/e turne6 their attention to 5ro/i6e 6ifferent ;in6s of facilities to their 

    em5lo0ees in or6er to satisf0 their em5lo0ees& This stu60 teste6 factors affecting 3o7 satisfaction for 

     5harmaceuticals com5anies& The results suggest that the factors ha6 satisfactoril0 e:5laine6 3o7 satisfaction an6

    that the 5olic0 ma;ers an6 managers shoul6 focus on the factors that affect em5lo0ee 3o7 satisfaction2 if the0

    9ant to enhance their 7usinesses& Base6 on the results for the stan6ar6i

  • 8/20/2019 Mohit Final Project Pharma

    31/35

     

    Chapter

    0.0!.O#*AP+2

    BIBLIOGRAPHY 29

  • 8/20/2019 Mohit Final Project Pharma

    32/35

     www.google.com

     Business magazines (business times)

     'e3s (!(ers 8Econo"ic ti"es9 Ti"es of In#i!:.

    30

  • 8/20/2019 Mohit Final Project Pharma

    33/35

    %h!(ter

    ;UESTIO''AIRE 

    Questionnaire (only Study Purpose, Not for publicly)

    31

  • 8/20/2019 Mohit Final Project Pharma

    34/35

    Part A

    1. Nae !!!!!!!!!!!!!!!!!!!!!!!!!2. A"e a. 1#$2% b. 2%$3% c. 3%$%% d. abo&e %%3. 'arital Status a. 'arried b. narried. *ender a. 'ale b. +eale%. ccupation !!!!!!!!!!!!!!!!!!!!!!!!!-. 'ontly /ncoe a. belo %000 b. %001$20000 c. 20001$3%000

    d. abo&e 3%001.. Area a ural b. rban#. aste a. *eneral b. 4 c. S5S6

    Part 41. How you come in the industry?

    A. Interview . !irect.

    2. In which o" the "o##owin$ rew%rd system wou#d you #i&e to wor&?  A. 'iece r%te system . (i)ed *%#%ry +. (i)ed *%#ery,+ommission !.

    Any other

    3. Are you $ettin$ e-u%# w%$es "or e-u%# wor&?A. es . /o

    4. Are you re%dy "or e)tr% hrs. time wor&?  A. es . /o

    5. Are you h%vin$ o security in your com'%ny?  A. es . /o

    6. o security '#%ys very im'ort%nt ro#e to wor& moreA. A$ree . !is%$ree +. +%nt *%y

    7. eco$nition o" sincere eorts motiv%tes % 'erson wor& we##  A. A$ree . !is%$ree +. +%nt *%y

    8. he reco$nition o" $ood wor& i" considered "or 'romotion it wi## motiv%te the wor&ers towor& we##A. A$ree . !is%$ree +. +%nt *%y

    9. !o you $et %ny discount on medicines which %re 'roduced in your industry?  A. es . /o.

    10. Are you s%tised with your oA. es . /o

    11.Industry deduct your :(

    A. es . /o

      12. I" yes then how much

      A. e#ow 5; . 6;

  • 8/20/2019 Mohit Final Project Pharma

    35/35

      A. es . /o

    14.you never come *%turd%y  A. es . /o

      15. Any su$$estion "or the com'%ny?

    ==========.

      16. ou w%nt to %ny other "%ci#ity in your industry?

      BBBBBBBBBB